Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | KMO | O15229 | 2/20 | 0.44 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21103888 | 0.98 | MEN1 (0.52) | PARP1MEN1RAB9AKMT2AKMO | |
| SCHEMBL10032413 | 0.96 | MEN1 (0.50) | PARP1MEN1RAB9AKMT2AKMO | |
| SCHEMBL21103662 | 0.96 | MEN1 (0.50) | PARP1MEN1RAB9AKMT2AKMO | |
| SCHEMBL21103770 | 0.96 | MEN1 (0.50) | PARP1MEN1RAB9AKMT2AKMO | |
| SCHEMBL31326563 | 0.96 | MEN1 (0.54) | PARP1MEN1RAB9AKMT2AKMO | |
| SCHEMBL10032415 | 0.96 | MEN1 (0.54) | PARP1MEN1RAB9AKMT2AKMO | |
| SCHEMBL10032340 | 0.96 | MEN1 (0.54) | PARP1MEN1RAB9AKMT2AKMO | |
| SCHEMBL21103672 | 0.94 | PARP1 (0.49) | PARP1MEN1RAB9AKMT2AKMO | |
| SCHEMBL21103768 | 0.94 | PARP1 (0.49) | PARP1MEN1RAB9AKMT2AKMO | |
| SCHEMBL21103679 | 0.94 | PARP1 (0.49) | PARP1MEN1RAB9AKMT2AKMO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11711972-B1 | Organic electronic element comprising compound for organic electronic element and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11711972-B1 | Organic electronic element comprising compound for organic electronic element and an electronic device thereof | PPOX, ESR1, CCNE2 | PARP1 1212/4885MEN1 703/4885RAB9A 3491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.